Top

Journal of General Internal Medicine

Published in:

01-02-2014 | Reply Letter

Marijuana Use and Health in Primary Care

Authors: Daniel Fuster, MD, PhD, Jeffrey H. Samet, MD, MA, MPH, Richard Saitz, MD, MPH

Published in: Journal of General Internal Medicine | Issue 2/2014

Excerpt

The Authors’ Reply—We read with interest the letter by Chukwuemeka1 addressing our recently published research.2 …

Chukwuemeka O. Marijuana use and health in primary care. J Gen Intern Med. 2013.

Fuster D, Cheng DM, Allensworth-Davies D, Palfai TP, Samet JH, Saitz R. No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use. J Gen Intern Med. 2013. doi:10.1007/s11606-013-2605-z.

Arendt M, Munk-Jorgensen P, Sher L, Jensen SO. Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: A nationwide follow-up study of Danish substance users in treatment. Drug Alcohol Depend. 2011;114(2–3):134–9.PubMed

Title: Marijuana Use and Health in Primary Care
Authors: Daniel Fuster, MD, PhD
Jeffrey H. Samet, MD, MA, MPH
Richard Saitz, MD, MPH
Publication date: 01-02-2014
Publisher: Springer US
Published in: Journal of General Internal Medicine / Issue 2/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-013-2705-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Marijuana Use and Health in Primary Care

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2014

Capsule Commentary on Radin, Pitfalls in Hemoglobin A1c Measurement: When Results May Be Misleading

Capsule Commentary on Turner et al., Chronic Opioid Therapy Risk Reduction Initiative: Impact on Urine Drug Testing Rates and Results

Capsule Commentary on Patrick et al., Trends in Insulin Initiation and Treatment Intensification among Patients with Type 2 Diabetes

Physicians, Politics, and Health Insurance Expansion

Physicians’ Roles in Creating Health Literate Organizations: A Call to Action

Patient Activation and 30-Day Post-Discharge Hospital Utilization

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page